Metagenomi Inc [MGX] stock prices are up 8.45% to $1.54 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MGX shares have gain 6.94% over the last week, with a monthly amount drifted -7.78%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Metagenomi Inc [NASDAQ: MGX] stock has seen the most recent analyst activity on May 07, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, JP Morgan downgraded its rating to Neutral on May 02, 2024, and dropped its price target to $6. On March 05, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $25 on the stock. TD Cowen started tracking the stock assigning a Outperform rating. JP Morgan initiated its recommendation with a Overweight and recommended $16 as its price target on March 05, 2024. Jefferies started tracking with a Buy rating for this stock on March 05, 2024, and assigned it a price target of $23. In a note dated March 05, 2024, Chardan Capital Markets initiated an Buy rating and provided a target price of $21 on this stock.
The stock price of Metagenomi Inc [MGX] has been fluctuating between $1.23 and $5.50 over the past year. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Metagenomi Inc [NASDAQ: MGX] shares were valued at $1.54 at the most recent close of the market. An investor can expect a potential return of 841.56% based on the average MGX price forecast.
Analyzing the MGX fundamentals
The Metagenomi Inc [NASDAQ:MGX] reported sales of 45.26M for trailing twelve months, representing a drop of -63.02%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -1.94%, Pretax Profit Margin comes in at -1.84%, and Net Profit Margin reading is -1.72%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is -0.32 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4468 points at the first support level, and at 1.3537 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5963, and for the 2nd resistance point, it is at 1.6527.
Ratios To Look Out For
It’s worth pointing out that Metagenomi Inc [NASDAQ:MGX]’s Current Ratio is 5.85. Further, the Quick Ratio stands at 5.85, while the Cash Ratio is 0.73. Considering the valuation of this stock, the price to sales ratio is 1.27, the price to book ratio is 0.27.
Transactions by insiders
Recent insider trading involved Wein Matthew, that happened on Jun 06 ’25 when 199.0 shares were sold. Chief Medical Officer, Noonberg Sarah B. completed a deal on Jun 06 ’25 to sell 5239.0 shares. Meanwhile, Chief Financial Officer Wapnick Pamela sold 1576.0 shares on Jun 06 ’25.
